Frankfurt - Delayed Quote EUR
FluoGuide A/S (96X.F)
3.3000
+0.1300
+(4.10%)
At close: April 22 at 3:29:02 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-32,784
-29,152
-31,809
-37,645
-15,062
Investing Cash Flow
-967
-987
-37
-117
--
Financing Cash Flow
44,963
27,080
27,500
17,018
51,183
End Cash Position
20,157
18,608
21,668
26,013
46,758
Capital Expenditure
--
-850
--
-64
--
Issuance of Capital Stock
47,201
39,301
17,809
17,870
55,148
Issuance of Debt
--
--
10,000
--
--
Free Cash Flow
-33,573
-30,002
-31,809
-37,709
-15,062
12/31/2021 - 3/11/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HTD.MU Corcept Therapeutics Inc
54.76
-5.42%
19X.SG Axsome Therapeutics Inc
90.74
-1.28%
BT3.BE Lineage Cell Therapeutics Inc
0.3360
-6.67%
MVR0.BE Medivir AB
0.1346
-1.90%
DBV.F DBV Technologies S.A.
1.2520
0.00%
0M4.DU Mersana Therapeutics Inc
0.3224
+2.12%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
300759.SZ Pharmaron Beijing Co., Ltd.
22.56
+1.53%
MVR0.F Medivir AB (publ)
0.1452
-0.41%
PL3.F TuHURA Biosciences, Inc.
3.5000
-0.57%